Edition:
United Kingdom

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

44.44CHF
14 Dec 2018
Change (% chg)

CHF-1.86 (-4.02%)
Prev Close
CHF46.30
Open
CHF46.20
Day's High
CHF46.42
Day's Low
CHF44.40
Volume
55,478
Avg. Vol
74,198
52-wk High
CHF81.45
52-wk Low
CHF44.02

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 46.62 -2.074
FY 2017 Dec '17 49.51 0.111
Jun '17 41.17 -1.899
FY 2016 Dec '16 35.31 -2.308
Jun '16 29.72 -2.759
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 42.15 66.40 17.90 --
Quarter Ending Dec-19 1 46.00 46.00 46.00 --
Year Ending Dec-18 7 121.54 129.00 104.00 91.25
Year Ending Dec-19 7 130.68 143.00 118.00 98.05
Earnings (per share)
Quarter Ending Dec-18 2 -2.35 -1.45 -3.24 --
Quarter Ending Dec-19 1 -1.56 -1.56 -1.56 --
Year Ending Dec-18 6 -2.94 -2.43 -3.52 -2.59
Year Ending Dec-19 6 -2.15 -1.14 -3.54 -0.55
LT Growth Rate (%) 1 -19.20 -19.20 -19.20 --
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta 1.31 1.08 0.91
Price to Sales (TTM) 12.39 49.58 6.22
Price to Book (MRQ) -- 10.17 5.20
Price to Tangible Book (MRQ) -- 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions -- 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg 1.21 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 38.49 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 35.14 47.89 6.50
Sales - 5 Yr. Growth Rate -0.50 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.18 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago 28.13 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -34.31 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.78 2.18 2.28
Current Ratio (MRQ) 2.98 3.44 3.10
LT Debt to Equity (MRQ) -- 18.69 11.49
Total Debt to Equity (MRQ) -- 31.36 16.03
Interest Coverage (TTM) -17.38 -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.31 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -45.22 -- --
EBITD - 5 Yr. Avg -84.28 -110.03 13.16
Operating Margin (TTM) -48.03 -185.03 6.07
Operating Margin - 5 Yr. Avg. -89.66 -126.47 8.47
Pre-Tax Margin (TTM) -56.97 -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -92.75 -132.63 8.71
Net Profit Margin (TTM) -57.44 -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -93.21 -137.03 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 318,667 7,648,872 873,051,409
Net Income/Employee (TTM) -183,042 653,324 103,483,755
Receivable Turnover (TTM) 27.34 6.25 5.80
Inventory Turnover (TTM) 0.45 1.89 3.56
Asset Turnover (TTM) 0.24 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.74 6.47 11.45
Return on Assets - 5 Yr. Avg. -14.90 5.54 12.50
Return on Investment (TTM) -17.70 9.01 14.96
Return on Investment - 5 Yr. Avg. -18.35 6.87 16.23
Return on Equity (TTM) -- 10.15 16.52
Return on Equity - 5 Yr. Avg. -78.01 8.40 17.37
  1 Year 3 Year 5 Year
Sales % 25.91 16.67 -0.50
EPS (TTM) % 16.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -4.81 99 98
13 Week -1.24 -5.17 99 94
26 Week -5.55 -11.79 99 98
52 Week 5.61 -6.73 99 68
YTD 9.37 -2.83 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.85%
# of Holders: 64
Total Shares Held: 3,901,702
3 Mo. Net Change: 442,606
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 13
# Reduced Positions: 8
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.